Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. COLLABORATION AGREEMENT between MEDIMMUNE, INC. and INFINITY PHARMACEUTICALS, INC. dated as of August 25, 2006Collaboration Agreement • November 1st, 2006 • Medimmune Inc /De • Biological products, (no disgnostic substances)
THIS COLLABORATION AGREEMENT dated as of the 25th day of August, 2006 (the “Agreement”) is made between MedImmune, Inc., a Delaware corporation having its principal place of business at One MedImmune Way, Gaithersburg, Maryland 20878 (“MedImmune”) and Infinity Pharmaceuticals, Inc., a Delaware corporation having its principal office at 780 Memorial Drive, Cambridge, Massachusetts 02139 (“Infinity”).
